Brian Rosenbloom

Brian Rosenbloom

Rothwell, Figg, Ernst & Manbeck, P.C.

Contact
View Bio
RSS

Latest Posts › Inventors

Share:

Continued Investment in AI Drug Discovery Points to Potential Future Significance of Inventorship in Biosimilar Litigation

On December 3, 2024, Bristol Myers Squibb announced a collaboration agreement with three-year-old startup AI Proteins. According to its founder, Chris Bahl, PhD, AI Proteins uses “AI, synthetic biology, and laboratory...more

12/20/2024  /  Artificial Intelligence , Biosimilars , BPCIA , Inventors , Investment , Patent Litigation , Patents , Prescription Drugs , Research and Development , USPTO

The USPTO’s Inventorship Guidance for AI-Assisted Inventions

Last year, the USPTO ruled that an artificial intelligence (AI) cannot be listed as an inventor on a patent application. See USPTO Says AI Machine Cannot Qualify as an Inventor (e.g., “Robert Bahr, Deputy Commissioner for...more

2/13/2024  /  Artificial Intelligence , Design Patent , Inventors , Machine Learning , New Guidance , Patent Applications , Patent-Eligible Subject Matter , Patents , USPTO
2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide